KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Cost of Revenue (2016 - 2025)

Astrana Health (ASTH) has disclosed Cost of Revenue for 16 consecutive years, with $855.5 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 39.16% to $855.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Dec 2025, up 61.09% year-over-year, with the annual reading at $2.8 billion for FY2025, 61.09% up from the prior year.
  • Cost of Revenue hit $855.5 million in Q4 2025 for Astrana Health, roughly flat from $858.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $858.9 million in Q3 2025 to a low of $136.2 million in Q2 2021.
  • Historically, Cost of Revenue has averaged $365.8 million across 5 years, with a median of $291.1 million in 2023.
  • Biggest five-year swings in Cost of Revenue: decreased 2.49% in 2021 and later soared 111.95% in 2025.
  • Year by year, Cost of Revenue stood at $171.8 million in 2021, then skyrocketed by 47.3% to $253.1 million in 2022, then rose by 24.07% to $314.1 million in 2023, then skyrocketed by 95.74% to $614.7 million in 2024, then surged by 39.16% to $855.5 million in 2025.
  • Business Quant data shows Cost of Revenue for ASTH at $855.5 million in Q4 2025, $858.9 million in Q3 2025, and $576.8 million in Q2 2025.